Endocrine Abstracts

Objectives: To evaluate the usefulness of an Annual Review Questionnaire (ARQ) which was introduced as a clinical tool to assess Knowledge and Compliance of Children and Young People (CYP) with Type 1 diabetes with aspects of good clinical care as defined by National Institute of Clinical Excellence (NICE) guideline.

Methods: All CYP with Type 1 diabetes, were expected to complete the ARQ as part of annual review. The questionnaire asked about compliance and knowledge of aspects of good clinical care. CYP with diabetes duration < 3 months prior to audit period and those with Type 2 diabetes were excluded.

Results: Data on the first 80 patients who completed the questionnaire between Feb-march 2018 was analyzed. 48.8% were males, 50% >12, 43.8% 12-5 and 6.3% <5 years old. 60.8% were White, 26.6% Asian, 11.4% African and Caribbean and 1.3% mixed race. 47.5% were on insulin pump. They were divided into 3 groups according to HbA1c level. Group A: HBA1c <7.5% (29/80), Group B: HBA1c=7.5–9% (36/80) and Group C HBA1c>9% (15/80). Compared to the whole group, significantly more children in group A were aware of their glucose targets (89.7% vs 70% P=0.01), reported never missing insulin bolus (85.7% vs 79.5% P−0.00) and reported testing blood glucose >4 times a day (93.1% vs 75.9% P=0.00). Only 76.3% of all patients were using level 3 carbohydrate counting to determine premeal bolus insulin dose and only 57.5% were bolusing insulin with snacks.

Conclusions: The ARQ identified areas of both good and poor compliance and knowledge amongst CYP with Type 1 diabetes. This helped the diabetes team to try to target education to individual CYP in problem areas identified. CYP in group A showed statistically significant better compliance in some areas.